<DOC>
	<DOCNO>NCT01766167</DOCNO>
	<brief_summary>To conduct follow evaluation Korean healthy male adult volunteer receive single multiple dos MP-424 tablet : - Pharmacokinetics MP-424 single multiple dos . - Safety tolerability single multiple dos MP-424 .</brief_summary>
	<brief_title>Clinical Pharmacology Study MP-424</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>Korean healthy male volunteer age 20 55 year Subjects BMI &lt; 18.5 &gt; 25.0 , body weight &lt; 50kg prior examination Subjects surgery know affect gastrointestinal absorption drug ( except appendectomy hernia surgery ) Subjects evidence cardiac disease prior examination previous history cardiac disease Subjects positive HBs antigen , serologic test syphilis , HCV antibody , HIV antibody prior examination Subjects experience symptom alcohol abuse excessive alcohol ingestion Subjects test positive urinalysis drug use ( amphetamine , benzodiazepine , barbiturate , cannabinoid , cocaine , opiates , methadone ) prior examination Subjects agree use physical contraceptive method study period Subjects agree use contraceptive method 90 day final administration study drug Subjects consume grapefruit , Seville orange , star fruit , cranberry , process food contain fruit within 7 day commencement study drug administration Subjects consume health food contain St John 's Wort within 2 week study drug administration</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Genotype 2</keyword>
</DOC>